PCSK9靶向肾近端小管megalin并加重肾病综合征蛋白尿
研究提出蛋白尿与PCSK9的机制耦合:PCSK9经肾小球滤过被近端小管megalin捕获,PCSK9负调控megalin并促进其溶酶体转运;足细胞损伤或微小病变时小管PCSK9摄取及尿PCSK9排泄增强,药理学抑制PCSK9可增加肾脏megalin并减少肾病小鼠尿白蛋白排泄。
要点
- PCSK9经肾小球滤过并被近端小管megalin捕获,是megalin的负调控因子。
- 足细胞损伤或微小病变时小管PCSK9摄取及尿PCSK9排泄增强。
- 药理学抑制PCSK9可增加肾病小鼠肾脏megalin并减少尿白蛋白排泄。
核心结论
- 肾小球损伤增加PCSK9滤过并伴随megalin降解,导致蛋白尿加重。
研究设计与样本
- 研究涉及 megalin 缺陷小鼠、携带 megalin 致病性变异的 Donnai Barrow 综合征患者、PCSK9 敲除与过表达小鼠、podocin 敲除小鼠、微小病变患者及培养的近端小管细胞。
主要发现
- megalin缺陷小鼠和携带megalin致病性变异的Donnai Barrow综合征患者尿PCSK9排泄升高。
- PCSK9敲除小鼠肾脏megalin增加,而PCSK9过表达导致其减少。
- PCSK9在培养的近端小管细胞中促进megalin向溶酶体转运。
- podocin敲除小鼠或微小病变患者中,小管PCSK9摄取和尿PCSK9排泄增强。
- 药理学PCSK9抑制增加肾病小鼠肾脏megalin并减少尿白蛋白排泄。
临床怎么用
- PCSK9抑制在肾病小鼠中增加肾脏megalin并减少尿白蛋白排泄,提示其可能影响蛋白尿。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Proteinuria is a prominent feature of chronic kidney disease. Interventions that reduce proteinuria slow the progression of chronic kidney disease and the associated risk of cardiovascular disease. Here, we propose a mechanistic coupling between proteinuria and proprotein convertase subtilisin/kexin type 9 (PCSK9), a regulator of cholesterol and a therapeutic target in cardiovascular disease. PCSK9 undergoes glomerular filtration and is captured by megalin, the receptor responsible for driving protein reabsorption in the proximal tubule. Accordingly, megalin-deficient mice and patients carrying megalin pathogenic variants (Donnai Barrow syndrome) were characterized by elevated urinary PCSK9 excretion. Interestingly, PCSK9 knockout mice displayed increased kidney megalin while PCSK9 overexpression resulted in its reduction. Furthermore, PCSK9 promoted trafficking of megalin to lysosomes in cultured proximal tubule cells, suggesting that PCSK9 is a negative regulator of megalin. This effect can be accelerated under disease conditions since either genetic destruction of the glomerular filtration barrier in podocin knockout mice or minimal change disease (a common cause of nephrotic syndrome) in patients resulted in enhanced tubular PCSK9 uptake and urinary PCSK9 excretion. Pharmacological PCSK9 inhibition increased kidney megalin while reducing urinary albumin excretion in nephrotic mice. Thus, glomerular damage increases filtration of PCSK9 and concomitantly megalin degradation, resulting in escalated proteinuria.
引用
- Skeby CK, Hummelgaard S, Gustafsen C, et al. Proprotein convertase subtilisin/kexin type 9 targets megalin in the kidney proximal tubule and aggravates proteinuria in nephrotic syndrome. Kidney Int. 2023. PMID: 37406929. doi:10.1016/j.kint.2023.06.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。